A carregar...

The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug

The interaction of temozolomide (TMZ) (the main chemotherapeutic agent for brain tumors) with blood components has not been studied at the molecular level to date, even though such information is essential in the design of dosage forms for optimal therapy. This work explores the binding of TMZ to hu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomolecules
Main Authors: Rubio-Camacho, Marta, Encinar, José A., Martínez-Tomé, María José, Esquembre, Rocío, Mateo, C. Reyes
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7408562/
https://ncbi.nlm.nih.gov/pubmed/32659914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10071015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!